IP Library Granted Patent US 10,435,723
Granted Patent B2
US 10,435,723 · App. 15/140,384 · Granted Oct 8, 2019

Adipate (ester or thioester) synthesis

Inventors: Liang Wu (Delft, NL); Axel Christoph Trefzer (Leidschendam, NL); Stefaan Marie Andre De Wildeman (Maasmechelen, BE); Marco Alexander Van Den Berg (Poeldijk, NL)
Assignee: Genomatica, Inc.
C12P7/44C12N15/70C12P7/62C12P17/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,435,723
App. No.
15/140,384
Granted
Oct 8, 2019
Kind
B2
Abstract

The present invention relates to a method for preparing an adipate ester or thioester. The invention further relates to a method for preparing adipic acid from said ester or thioester. Further the invention provides a number of methods for preparing an intermediate for said ester or thioester. Further the invention relates to a method for preparing 6-amino caproic acid (6-ACA), a method for preparing 5-formyl valeric acid (5-FVA), and a method for preparing caprolactam. Further, the invention relates to a host cell for use in a method according to the invention.

Claims (20)

1. A method for preparing an adipate ester or adipate thioester, comprising converting a 2,3-dehydroadipate ester or 2,3-dehydroadipate thioester into the adipate ester or thioester in the presence of a biocatalyst, wherein the biocatalyst comprises an enzyme, wherein said enzyme comprises the amino acid sequence of SEQ ID NO:60 or an amino acid sequence that has at least 90% sequence identity to SEQ ID NO:60, and wherein said enzyme catalyzes the conversion of 2,3-dehydroadipate ester or 2,3-dehydroadipate thioester into the adipate ester or thioester.

2. The method of claim 1 , wherein said enzyme comprises an amino acid sequence that has at least 93% sequence identity to residues 23-386 of SEQ ID NO:60.

3. The method of claim 1 , wherein said enzyme comprises an amino acid sequence that has at least 94% sequence identity to residues 23-386 of SEQ ID NO:60.

4. The method of claim 1 , wherein said enzyme comprises an amino acid sequence that has at least 95% sequence identity to residues 23-386 of SEQ ID NO:60.

5. The method of claim 1 , wherein said enzyme comprises an amino acid sequence that has at least 98% sequence identity to residues 23-386 of SEQ ID NO:60.

6. The method of claim 1 , wherein said enzyme comprises an amino acid sequence that has at least 99% sequence identity to residues 23-386 of SEQ ID NO:60.

7. The method according to claim 1 , wherein the enzyme comprises the amino acid sequence of SEQ ID NO:60.

8. The method according to claim 1 , wherein said biocatalyst is a host cell comprising said enzyme.

9. The method according to claim 8 , wherein said host cell is a microorganism.

10. The method according to claim 9 , wherein said microorganism is a bacterium, yeast or fungi.

11. The method according to claim 9 , wherein said microorganism is selected from the group consisting of Escherichia coli, Bacillus subtilis, Bacillus amyloliquefaciens, Corynebacterium glutamicum, Aspergillus niger, Penicillium chrysogenum, Pichia pastoris , and Saccharomyces cerevisiae.

12. The method according to claim 1 , wherein said 2,3-dehydroadipate ester or 2,3-dehydroadipate thioester is prepared by converting a 3-hydroxyadipate ester or 3-hydroxyadipate thioester to 2,3-dehydroadipate ester or 2,3-dehydroxyadipate thioester, respectively.

13. The method according to claim 12 , wherein said 3-hydroxyadipate ester or 3-hydroxyadipate thioester is biocatalytically converted in the presence of a biocatalyst comprising an enzyme capable of catalysing the dehydration of a 3-hydroxyacyl ester or 3-hydroxyacyl thioester to 2-enoyl ester or 2-enoyl thioester.

14. The method according to claim 13 , wherein said enzyme capable of catalysing the dehydration of a 3-hydroxyacyl ester or 3-hydroxyacyl thioester to 2-enoyl ester or 2-enoyl thioester is selected from the group consisting of an enoyl-CoA hydratase, a 3-hydroxybutyryl-CoA dehydratase and a long-chain-enoyl-CoA hydratase.

15. The method according to claim 12 , wherein said 3-hydroxyadipate ester or 3-hydroxyadipate thioester is prepared by converting a 3-oxoadipate ester or 3-oxoadipate thioester to said 3-hydroxyadipate ester or 3-hydroxyadipate thioester, respectively.

16. The method according to claim 15 , wherein said 3-oxoadipate ester or 3-oxoadipate thioester is biocatalytically converted in the presence of a biocatalyst comprising an enzyme capable of catalysing the reduction of a carbonyl group to an alcohol group or capable of catalysing the reduction of a 3-oxoacyl ester or 3-oxoacyl thioester to 3-hydroxyacyl ester or 3-hydroxyacyl thioester.

17. The method according to claim 16 , wherein said enzyme capable of catalyzing the reduction of a carbonyl group to an alcohol group or capable of catalyzing the reduction of a 3-oxoacyl ester or 3-oxoacyl thioester to 3-hydroxyacyl ester or 3-hydroxyacyl thioester is selected from the group consisting of a 3-hydroxyacyl-CoA dehydrogenase, a 3-hydroxybutanoyl-CoA dehydrogenase, a 3-hydroxypimeloyl-CoA dehydrogenase and a long-chain-3-hydroxyacyl-CoA dehydrogenase.

18. The method according to claim 15 , wherein said 3-oxoadipate ester or 3-oxoadipate thioester is prepared by converting a succinate ester or succinate thioester and an acetate ester or acetate thioester to 3-oxoadipate ester or 3-oxoadipate thioester.

19. The method according to claim 18 , wherein said 3-oxoadipate ester or 3-oxoadipate thioester is biocatalytically converted in the presence of a biocatalyst comprising an enzyme capable of acetyl-group transfer.

20. The method of claim 19 , wherein said enzyme capable of acetyl-group transfer is selected from the group consisting of an acetyl-CoA:acetyl-CoA C-acetyltransferase, an acyl-CoA:acetyl-CoA C-acetyltransferase and an succinyl-CoA:acetyl-CoA C-succinyltransferase.

Assignments (3)
SECURITY INTEREST Recorded Feb 10, 2026
From: GENOMATICA, INC.
To: AGAIN BIO APS
Reel/Frame 074708/0001 →
SECURITY INTEREST Recorded Dec 9, 2025
From: GENOMATICA, INC.
To: NOVO HOLDINGS A/S, AS COLLATERAL AGENT
Reel/Frame 073915/0027 →
SECURITY INTEREST Recorded Jun 2, 2025
From: GENOMATICA, INC.
To: OXFORD FINANCE LLC
Reel/Frame 071471/0770 →
Priority Claims (1)
EP 08152595 · Mar 11, 2008 · regional
Continuity (5)
Continuation 14082000 · Nov 15, 2013
Continuation 13841142 · Mar 15, 2013
Continuation 13572346 · Aug 10, 2012
Continuation 12921547
Related Publication 20170073708A1 · Mar 16, 2017